Compare Adaptive Biotechnologies Corp (ADPT) vs BigBearai Holdings Inc (BBAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs BigBearai Holdings Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while BigBearai Holdings Inc trades at $3.34 (market cap $1.60B). The key difference: Adaptive Biotechnologies Corp is far larger — about 2.5× BigBearai Holdings Inc's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, BigBearai Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | BBAI | |
|---|---|---|
Market Cap | $4.04B | $1.60B |
Sector | Health | Technology |
52-Week High | $25.45 | $8.91 |
52-Week Low | $12.30 | $2.61 |
Enterprise Value | $4.10B | $1.30B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About BigBearai Holdings Inc
BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →
